My Cart

T4 RNA Ligase 1

T4 RNA Ligase 1 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Escherichia phage T4 (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
Escherichia phage T4
E. coli
T4 RNA Ligase 1(10U/ul) Add to Cart
Total: 1
  • 1

T4 RNA Ligase 1 Background

Circular RNAs (circRNA) is a class of natural (biogenic) or synthetic closed RNA without 5' or 3' ends. Meanwhile, their unique covalently-closed structures of circRNA prevent RNA degradation by exonucleases, thereby empowering them with high pharmaceutical stability and biostability relative to current standard-of-care linear mRNA. Natural circRNA can be non-coding RNAs as well as protein-coding RNA, the latter of which was recently discovered. The physiological functions of biogenic circRNAs, which largely remain elusive, include protein and gene sponges, cell activity modulators, and protein translation. The discovery that the circRNA levels can be correlated with some human diseases empowers circRNA with the potential as a novel type of disease biomarkers and a noncanonical class of therapeutic targets. Recently, synthetic circRNA have been engineered to explore their applications as a novel class of mRNA therapeutics and vaccines.(Liu, Xiang et al. “Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines.” Journal of controlled release : official journal of the Controlled Release Society vol. 348 (2022): 84-94. doi:10.1016/j.jconrel.2022.05.043)

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
ItolizumabT-1-hT; EQ-001; T-1-h; h-T1; Bmab-600ApprovedBiocon Ltd, Center Of Molecular Immunology, Biotech Pharmaceuticals Co LtdAlzumabIndiaPlaque psoriasisBiocon Ltd2013-01-01Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Nephritis; Respiratory Distress Syndrome, Adult; Psoriasis; Asthma; Plaque psoriasis
Details
  • Product List
  • Marketed Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland